Bioequivalence of the Highest Dose Strength Fixed-Dose Combination Tablet Of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects
Background In type 2 diabetes mellitus, the combined use of agents with complementary mechanisms of action improves glucose control via correction of multiple pathophysiologic defects. Fixed-dose combination (FDC) therapy can offer not only these benefits, but also potentially increase patient compl...
Saved in:
| Published in | Clinical therapeutics Vol. 39; no. 8; p. e53 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Bridgewater
Elsevier Inc
01.08.2017
Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0149-2918 1879-114X |
| DOI | 10.1016/j.clinthera.2017.05.165 |
Cover
Loading…
| Abstract | Background In type 2 diabetes mellitus, the combined use of agents with complementary mechanisms of action improves glucose control via correction of multiple pathophysiologic defects. Fixed-dose combination (FDC) therapy can offer not only these benefits, but also potentially increase patient compliance. |
|---|---|
| AbstractList | Background In type 2 diabetes mellitus, the combined use of agents with complementary mechanisms of action improves glucose control via correction of multiple pathophysiologic defects. Fixed-dose combination (FDC) therapy can offer not only these benefits, but also potentially increase patient compliance. |
| Author | Lee, S. Hyang Cho, Y.-S. Bae, K.-S. Lim, H.-S. Jung, J. Hyuk |
| Author_xml | – sequence: 1 givenname: Y.-S. surname: Cho fullname: Cho, Y.-S. organization: Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Korea – sequence: 2 givenname: S. Hyang surname: Lee fullname: Lee, S. Hyang organization: Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Korea – sequence: 3 givenname: J. Hyuk surname: Jung fullname: Jung, J. Hyuk organization: LG Life Sciences Ltd, Seoul, Korea – sequence: 4 givenname: H.-S. surname: Lim fullname: Lim, H.-S. organization: Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Korea – sequence: 5 givenname: K.-S. surname: Bae fullname: Bae, K.-S. organization: Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Korea |
| BookMark | eNqNkt1qGzEQhZeSQp20z1BBb9qL3UjaX920pG4TB1ICdgq5E9Jq1pa7lhxJa-pnzEtFG4emFAq5EhJnvpmjM8fJkbEGkuQ9wRnBpDpdZ22vTViBExnFpM5wmZGqfJVMSFOzlJDi9iiZYFKwlDLSvEmOvV9jjHNW0kly_1VbuBv0TvRgWkC2QxGFZnq5Ah_QN-sBLYIDswwrdK5_g0of36Z2I7URQVuDboTsIaDrDl3ARi97vQ3anP6A0Fm30QYtBh-ENqDQHHoQsfrjYv4JCaPQpVF6p9Ug-pG4jc5M-JvyKHom3c6fmnkUbzMQfVjtI1-uoQ3-bfK6E72Hd0_nSfLz_PvNdJZeXV9cTs-u0pYWZZ0KUhOoZVOVgjaqqlQuJVYdoxgLoISpAhopoSOyrVWRA6tqUTSMUaJkUbQiP0k-HLhbZ--G-E18bQdnYktOGKFVlRdNHVX1QdU6672Djm-d3gi35wTzMTm-5n-S42NyHJc8Jhcrzw6VEE3sNDjuWz2mo7SLPrmy-gWMz_8wRp1uRf8L9uCfB-aecswX436M60HqHBcVZRHw5f-AF43wAKLD1o8 |
| ContentType | Journal Article |
| Copyright | 2017 Copyright Elsevier Limited Aug 2017 |
| Copyright_xml | – notice: 2017 – notice: Copyright Elsevier Limited Aug 2017 |
| DBID | AAYXX CITATION 3V. 7RV 7X7 7XB 88C 88E 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. KB0 M0S M0T M1P M2O M7N MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U |
| DOI | 10.1016/j.clinthera.2017.05.165 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Healthcare Administration Database Medical Database ProQuest_Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
| DatabaseTitle | CrossRef Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
| DatabaseTitleList | Research Library Prep |
| Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1879-114X |
| EndPage | e53 |
| ExternalDocumentID | 10_1016_j_clinthera_2017_05_165 S0149291817304629 1_s2_0_S0149291817304629 |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1~. 1~5 29B 4.4 457 4G. 53G 5RE 5VS 6J9 6PF 7-5 71M 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABUWG ABWVN ABXDB ABZDS ACDAQ ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HMCUK HVGLF HZ~ H~9 IHE J1W KOM M0T M1P M2O M41 MO0 N9A NAPCQ O-L O9- OAUVE OD~ OGGZJ OO0 OZT P-8 P-9 PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSP SSZ SV3 T5K UHS UKHRP WH7 WOW XOL Z5R ZGI ZXP ~G- 0SF 3V. AACTN AAYOK AFCTW AFKWA AJOXV ALIPV AMFUW NCXOZ RIG AAIAV AATCM ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION 7XB 8FK K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U |
| ID | FETCH-LOGICAL-c2457-a171e7b865a28d66d3bb0df9200ae219d4e8bbef1bc7d43e967a489921db44ca3 |
| IEDL.DBID | AIKHN |
| ISSN | 0149-2918 |
| IngestDate | Wed Aug 13 10:34:45 EDT 2025 Tue Jul 01 04:21:46 EDT 2025 Fri Feb 23 02:30:12 EST 2024 Sun Feb 23 10:18:51 EST 2025 Tue Aug 26 16:32:07 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2457-a171e7b865a28d66d3bb0df9200ae219d4e8bbef1bc7d43e967a489921db44ca3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| PQID | 1912663487 |
| PQPubID | 1226358 |
| ParticipantIDs | proquest_journals_1912663487 crossref_primary_10_1016_j_clinthera_2017_05_165 elsevier_sciencedirect_doi_10_1016_j_clinthera_2017_05_165 elsevier_clinicalkeyesjournals_1_s2_0_S0149291817304629 elsevier_clinicalkey_doi_10_1016_j_clinthera_2017_05_165 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20170801 |
| PublicationDateYYYYMMDD | 2017-08-01 |
| PublicationDate_xml | – month: 08 year: 2017 text: 20170801 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Bridgewater |
| PublicationPlace_xml | – name: Bridgewater |
| PublicationTitle | Clinical therapeutics |
| PublicationYear | 2017 |
| Publisher | Elsevier Inc Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
| SSID | ssj0003952 |
| Score | 2.1956713 |
| Snippet | Background In type 2 diabetes mellitus, the combined use of agents with complementary mechanisms of action improves glucose control via correction of multiple... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | e53 |
| SubjectTerms | Antidiabetics Controlled release Diabetes mellitus Generic drugs Internal Medicine Medical Education Metformin Tablets |
| SummonAdditionalLinks | – databaseName: ProQuest_Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3raxQxEA9aQfwiWhXPVpkPUhS6dN_Z-EV8nVU4Ldcr3LeQbLLtit29ulvw_kb_KWeyj1Mp6sd9ZBKYZB6Z-c0w9lTlPE8FJ9iv8D20iLWn6NEvgihLyUJ3gfbZp_TwJP64TJb9hVvTp1UOMtEJalPndEd-gH4F6pIIqb1cXXjUNYqiq30LjevshitdhvuZL0eHy4-E67hDXoAXiiD7Lb-LkIcO40T5Xa58Z0Aa5mrt9Iecdspneofd7q1GeNWx-S67ZqttdnPWx8W32d5RV4F6vQ-LDaCq2Yc9ONrUpl7fYz9el7W9uCxxf9GRhroAXB24bI-mhbd1Y4EC1dVpewbT8rs1nnuHYgNdaMdFWBDaqoXPBby35-XpV5I61cHMtmT_lhUcd5gsa2COOg21JDw7nj8HVRn4MMK_iOKqrlDl_UrF_bShtJz3kzWATx1iao30NV0eNffZyfTd4s2h1_dz8PIwTrinAh5YrrM0UWFm0tREWvumEHhQlUXJaWKbaW2LQOfcxJEVKVcx-oNhYHQc5yp6wLYqXNlDBrmgzqIZLxItYqGM0r7KImO4b3Vqi3zC_IGPctWV7ZBDPtsXObJeEuuln0hk_YRlA7_lgEpFOSpRtfx7KL9qqG16edDIQDah9F0qnaCdGHCKSIdiwl6MI3uTpzNl_m_a3WFbys1M4zl59PfPO-wW0eqSGXfZVvvt0j5GA6vVT9wp-gnVdCjP priority: 102 providerName: ProQuest |
| Title | Bioequivalence of the Highest Dose Strength Fixed-Dose Combination Tablet Of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0149291817304629 https://www.clinicalkey.es/playcontent/1-s2.0-S0149291817304629 https://dx.doi.org/10.1016/j.clinthera.2017.05.165 https://www.proquest.com/docview/1912663487 |
| Volume | 39 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1db9MwFLW2TkK8IBggCtvkh2kCaaH5dszbNlY6UEvVdVLfLDt2RhCkhWQSfdkf5E9xr5O0G0wCiZdWjuJrt9c-5ya-xyZkX6YsjTlD2S93HYiIlSOx6GZekMQYoduF9uEoHlyE72fRbIOctFoYTKtssL_GdIvWzZVe82_2Fnnew7Qk4HZgKIarez7fJFt-wOOoQ7aOzj4MRitADrg9eAfvd7DCrTQvFCBaqROmedldPD0kmrtJ6je4thzUf0geNMEjPar794hsmGKb3Bs2y-Pb5GBcb0S9PKTTta6qPKQHdLzeonr5mPw8zufm21UOwwx_MZ1nFHpHbdJHWdG389JQXK8uLqtPtJ__MNqx1wA94EnaOpNOUXRV0Y8ZfWe-5pdfEHyK3tBUGAbnBT2vpVlG0wlQG5AlfXk-eUVloenZSgWGFhfzApjvphV709rSbNI0VlIo1cKpJdhX-A6pfEIu-qfTk4HTHOvgpH4YMUd6zDNMJXEk_UTHsQ6UcnXGYb5KAwCqQ5MoZTJPpUyHgeExkyE8FvqeVmGYyuAp6RTQs2eEphwPGE1YFikecqmlcmUSaM1co2KTpV3itn4Ui3r3DtGmtX0WK9cLdL1wIwGu75Kk9bdoxakApwIY5u9V2V1VTdnAQik8UfrCFX8M3S55s6p5a_T_W7M77bAU65a4B6FXAJPv-f_YfkHuY6nOeNwhner7ldmFKKxSe2Tz9bUHn2zG9poZB9_Hp6Px5BfQEDib |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEvCAZohQF-gAmkRctX4xgJIcZWWraWquukvhk7dkYQpB3JBP2n-Ef4p7hzkhbQBLzsMR8-W7rzffju5yPksUxYEnGGsF_uOuARK0fio5t6QRyhh24T7YNh1DsJ30470zXyvcHCYFlloxOtotazBM_IdyGuAFsSALWX8zMHu0ZhdrVpoVGJxaFZfIWQrXjR3wf-PvH97sHkdc-puwo4iR92mCM95hmm4qgj_VhHkQ6UcnXKQVykgf2rQxMrZVJPJUyHgeERkyFEJb6nVRgmMgC6V8h6iIjWFlnfOxiOxkvdH3Db4wfjDsfnXvxbRRliHS2qCivK7IWhHtq0i-3hH5bBmrvuTXKj9lPpq0qwbpE1k2-Qq4M6E79BtkfVndeLHTpZQbiKHbpNR6vbsBe3yY-9bGbOzjOQaFQidJZSWB219SVFSfdnhaGYGs9Pyw-0m30z2rHvQFFB0G7lhk4Q31XSdyl9Yz5np59Qz-W7A1Oix53l9LhCgRlNx2BFwS7Tp8fjZ1TmmvaXgDOkOJ_lYGR_pWJ_WlGajuvJCgpPFUZrAfQVHlcVd8jJpfD6LmnlsLJNQhOOvUxjlnYUD7nUUrkyDrRmrlGRSZM2cRs-inl1UYhoKug-iiXrBbJeuB0BrG-TuOG3aHCwoLkFGLN_D2UXDTVFrYEK4YnCF64t3uMoiR7DHLjP2-T5cmTtZFXO0_9Nu9WIpVjNtNyZ9_7--RG51psMjsRRf3h4n1xHulUp5RZplV_OzQNw70r1sN5TlLy_7G38E5wsZ4Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKkSouCAqI0AI-QAVSV9m310gIASE0lJQoTaXcXHvtbYNgk7JbQf4af4E_xYz3EUAVcOlxHx6vNO-d-TyEPJIpS2POEPbLXQciYuVIvHQzL0hijNBtoX14EO8dhe-m0XSNfG-wMNhW2dhEa6j1PMV_5F3IK8CXBECtm9VtEaNe_8XizMEJUlhpbcZpVCKyb5ZfIX0rng96wOvHvt9_M3m959QTBpzUDyPmSI95hqkkjqSf6DjWgVKuzjiIjjSgyzo0iVIm81TKdBgYHjMZQobie1qFYSoDoHuFXGUBRFWgS2zaJntuwO20H8xAHJ97yW-9ZYh6tPgq7C2zR4d66N0u9ox_-Ajr-Po3yPU6YqUvKxG7SdZMvkk2hnVNfpPsjKrTr5e7dLICcxW7dIeOVudiL2-RH69mc3N2PgPZRnNC5xmFr6O206QoaW9eGIpF8vykPKX92TejHXsPTBak71aC6ASRXiX9kNG35vPs5BNavLw7NCXG3rOcHlZ4MKPpGPwpeGj65HD8lMpc00ELPUOKi3kO7vZXKvalFaXpuN6soHBVobWWQF_hj6viNjm6FE7fIes5fNldQlOOU00TlkWKh1xqqVyZBFoz16jYZGmHuA0fxaI6MkQ0vXQfRct6gawXbiSA9R2SNPwWDSIWbLgAt_bvpeyipaaobVEhPFH4wrVtfBwl0WNYDfd5hzxrV9bhVhVG_d-2241YitVOrY7e-_vjh2QDlFe8Hxzsb5FrSLbqqdwm6-WXc3Mf4rxSPbAKRcnxZWvwT-h1aks |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bioequivalence+of+the+Highest+Dose+Strength+Fixed-Dose+Combination+Tablet+Of+Gemigliptin%2FMetformin+Sustained+Release+%28SR%29+and+Individual+Component+Gemigliptin+and+Metformin+XR+Tablets+in+Healthy+Subjects&rft.jtitle=Clinical+therapeutics&rft.au=Cho%2C+Y.-S.&rft.au=Lee%2C+S.+Hyang&rft.au=Jung%2C+J.+Hyuk&rft.au=Lim%2C+H.-S.&rft.date=2017-08-01&rft.pub=Elsevier+Inc&rft.issn=0149-2918&rft.volume=39&rft.issue=8&rft.spage=e53&rft.epage=e53&rft_id=info:doi/10.1016%2Fj.clinthera.2017.05.165&rft.externalDocID=S0149291817304629 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01492918%2FS0149291817X00088%2Fcov150h.gif |